Cabot (NYSE:CBT) Stock Moved Down to Hold by Wall Street Zen

Wall Street Zen downgraded shares of Cabot (NYSE:CBT) from a buy rating to a hold rating in a research note issued to investors on Saturday,Wall Street Zen reports.

Several other research analysts also recently weighed in on CBT. UBS Group decreased their price target on shares of Cabot from $97.00 to $92.00 and set a “neutral” rating on the stock in a research report on Wednesday, August 5th. JPMorgan Chase & Co. boosted their price objective on shares of Cabot from $70.00 to $78.00 and gave the company an “underweight” rating in a research report on Friday, August 7th. Truist Financial set a $100.00 price objective on Cabot in a research note on Wednesday, August 5th. Mizuho raised their target price on Cabot from $80.00 to $90.00 and gave the stock a “neutral” rating in a report on Thursday, June 25th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Cabot in a research report on Friday, August 21st. Two research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $89.00.

Cabot Trading Up 1.0%

Cabot stock opened at $77.14 on Friday. The business has a 50-day simple moving average of $82.83 and a two-hundred day simple moving average of $82.12. The company has a market cap of $3.98 billion, a P/E ratio of 21.73, a P/E/G ratio of 9.06 and a beta of 0.83. Cabot has a 52-week low of $58.33 and a 52-week high of $94.53. The company has a quick ratio of 0.97, a current ratio of 1.47 and a debt-to-equity ratio of 0.48.

Cabot (NYSE:CBT) last issued its quarterly earnings data on Monday, August 3rd. The specialty chemicals company reported $1.67 earnings per share for the quarter, topping the consensus estimate of $1.66 by $0.01. The firm had revenue of $982.00 million for the quarter, compared to analysts’ expectations of $943.16 million. Cabot had a net margin of 5.23% and a return on equity of 20.29%. The business’s quarterly revenue was up 6.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.90 EPS. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. Analysts predict that Cabot will post 6.35 EPS for the current year.

Cabot Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, September 11th. Shareholders of record on Friday, August 28th were given a $0.4725 dividend. This represents a $1.89 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date was Friday, August 28th. Cabot’s dividend payout ratio is presently 53.24%.

Insider Activity

In other news, CEO Sean Keohane sold 134,895 shares of the stock in a transaction on Friday, August 28th. The shares were sold at an average price of $85.00, for a total value of $11,466,075.00. Following the completion of the sale, the chief executive officer directly owned 404,134 shares of the company’s stock, valued at $34,351,390. This represents a 25.03% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders have sold 229,597 shares of company stock valued at $19,646,746 over the last three months. Corporate insiders own 3.08% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the company. QRG Capital Management Inc. increased its stake in Cabot by 6.0% in the 2nd quarter. QRG Capital Management Inc. now owns 3,433 shares of the specialty chemicals company’s stock worth $312,000 after buying an additional 194 shares in the last quarter. Envestnet Asset Management Inc. lifted its position in shares of Cabot by 1.7% in the second quarter. Envestnet Asset Management Inc. now owns 183,849 shares of the specialty chemicals company’s stock valued at $16,697,000 after acquiring an additional 3,068 shares in the last quarter. State Street Corp lifted its position in shares of Cabot by 6.8% in the second quarter. State Street Corp now owns 2,165,434 shares of the specialty chemicals company’s stock valued at $196,665,000 after acquiring an additional 138,098 shares in the last quarter. Integrated Wealth Concepts LLC bought a new position in shares of Cabot in the second quarter worth about $148,000. Finally, Paragon Capital Management Ltd bought a new position in shares of Cabot in the second quarter worth about $251,000. Hedge funds and other institutional investors own 93.18% of the company’s stock.

Cabot Company Profile

Cabot Corporation (NYSE: CBT) is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company develops and manufactures materials used by industrial and consumer-product manufacturers worldwide.

Cabot’s products include reinforcing carbon blacks used in tires, automotive components, and other rubber products; specialty carbon blacks used in coatings, plastics, inks, and batteries; and fumed silica used in adhesives, sealants, coatings, and personal-care applications.